Neprilysin

Handbook of Proteolytic Enzymes

Volumn 1, Issue , 2013, Pages 612-619

  Nalivaeva, Natalia N ^a,b   Turner, Anthony J ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884893908     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-382219-2.00127-7     Document Type: Chapter

References (92)

1. Wong-Leung Y.L., Kenny A.J. Some properties of a microsomal peptidase in rat kidney. Biochem. J. 1968, 110:5P.
2. Kerr M.A., Kenny A.J. The purification and specificity of a neutral endopeptidase from rabbit kidney brush border. Biochem. J. 1974, 137:477-488.
3. Turner A.J., Isaac R.E., Coates D. The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function. Bioessays 2001, 23:261-269.
4. Bland N.D., Pinney J.W., Thomas J.E., Turner A.J., Isaac R.E. Bioinformatic analysis of the neprilysin (M13) family of peptidases reveals complex evolutionary and functional relationships. BMC Evol. Biol. 2008, 8:16.
5. Malfroy B., Swerts J.P., Guyon A., Roques B.P., Schwartz J.-C. High-affinity enkephalin-degrading peptidase is increased after morphine. Nature 1978, 276:523-526.
6. Matsas R., Fulcher I.S., Kenny A.J., Turner A.J. Substance P and [Leu]enkephalin are hydrolyzed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli. Proc. Natl. Acad. Sci. USA 1983, 80:3111-3115.
7. Devault A., Lazure C., Nault C., Le Moual H., Seidah N.G., Chrétien M., Kahn P., Powell J., Mallet J., Beaumont A., Roques B.P., Crine P., Boileau G. Amino acid sequence of rabbit kidney neutral endopeptidase-24.11 (enkephalinase) deduced from a complementary DNA. EMBO J. 1987, 6:1317-1322.
8. LeTarte M., Vera S., Tran R., Addis J.B.L., Onizuka R.J., Quackenbush E.J., Jongeneel C.V., McInnes R.R. Common acute lymphocytic leukemia antigen is identical to neutral endopeptidases. J. Exp. Med. 1988, 168:1247-1253.
9. Joshi D.D., Dang A.J., Yadav P., Qian J., Bandari P.S., Chen K.H., Donnelly R., Castro T., Gascon P., Haider A., Rameshwar P. Negative feedback on the effects of stem cell factor on hematopoiesis is partly mediated through neutral endopeptidase activity on substance P: a combined functional and proteomic study. Blood 2001, 98:2697-2706.
10. Morisaki N., Moriwaki S., Sugiyama-Nakagiri Y., Haketa K., Takema Y., Imokawa G. Neprilysin is identical to skin fibroblast elastase: its role in skin aging and UV responses. J. Biol. Chem. 2010, 285:39819-39827.
11. Matsas R., Turner A.J., Kenny A.J. The metabolism of neuropeptides: the hydrolysis of peptides, including enkephalins, tachykinins and their analogues by endopeptidase-24.11. Biochem. J. 1984, 223:433-440.
12. Roques B.P., Beaumont A. Neutral endopeptidase-24.11 inhibitors: from analgesics to antihypertensives. Trends Pharmacol. Sci. 1990, 11:245-249.
13. Connelly J.C., Skidgel R.A., Schulz W.W., Johnson A.R., Erdös E.G. Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide. Proc. Natl. Acad. Sci. USA 1985, 82:8737-8741.
14. Pozsgay M., Michaud C., Liebman M., Orlowski M. Substrate and inhibitor studies of thermolysin-like neutral metalloendopeptidase from kidney membrane fractions. Comparison with bacterial thermolysin. Biochemistry 1986, 25:1292-1299.
15. Hersh L.B., Morihara K. Comparison of subsite specificity of the mammalian neutral endopeptidase-24.11 (enkephalinase) to the bacterial neutral endopeptidase, thermolysin. J. Biol. Chem. 1986, 261:6433-6437.
16. Bateman R.C., Jackson D., Slaughter C.A., Unnithan S., Chai Y.G., Moomaw C.A., Hersh L.B. Identification of the active site arginine in rat neutral endopeptidase 24.11 (enkephalinase) as Arg 102 and analysis of a glutamine 102 mutant. J. Biol. Chem. 1989, 264:6151-6157.
17. Pankow K., Schwiebs A., Becker M., Siems W.E., Krause G., Walther T. Structural substrate conditions required for neutral endopeptidase-mediated natriuretic peptide degradation. J. Mol. Biol. 2009, 393:496-503.
18. Turner A.J., Hooper N.M., Kenny A.J. Neuropeptide-degrading enzymes. Neuropeptides: A Methodology 1989, 189-223. John Wiley, Chichester. G. Fink, A.J. Harmar (Eds.).
19. Li C., Hersh L.B. Neprilysin: assay methods, purification and characterization. Methods Enzymol. 1995, 248:253-263.
20. Fisk L., Nalivaeva N.N., Boyle J.P., Peers C.S., Turner A.J. Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes. Neurochem. Res. 2007, 32:1741-1748.
21. Kerr M.A., Kenny A.J. The molecular weight and properties of a neutral metalloendopeptidase from rabbit kidney brush border. Biochem. J. 1974, 137:489-495.
22. Roques B.P., Fournié-Zaluski M.-C., Soroca E., Lecomte J.M., Malfroy B., Llorens C., Schwartz J.-C. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature 1980, 288:286-288.
23. Roques B.P., Noble F., Daugé V., Fournié-Zaluski M.-C., Beaumont A. Neutral endopeptidase 24.11. Structure, inhibition, and experimental and clinical pharmacology. Pharmacol. Rev. 1993, 45:87-146.
24. Sahli S., Stump B., Welti T., Blum-Kaelin D., Aebi J.D., Oefner C., Böhm H.J., Diederich F. Structure-based design, synthesis, and in vitro evaluation of nonpeptidic neprilysin inhibitors. Chembiochem. 2004, 5:996-1000.
25. Rougeot C., Messaoudi M., Hermitte V., Rigault A.G., Blisnick T., Dugave C., Desor.D., Rougeon F. Sialorphin, a natural inhibitor of rat membrane-bound neutral endopeptidase that displays analgesic activity. Proc. Natl. Acad. Sci. USA 2003, 100:8549-8554.
26. Fulcher I.S., Kenny A.J. Proteins of the kidney microvillar membrane. The amphipathic forms of endopeptidase purified from pig kidneys. Biochem. J. 1983, 211:743-753.
27. Shimada K., Takahashi M., Turner A.J., Tanzawa K. Rat endothelin-converting enzyme-1 forms a dimer through Cys(412) with a similar catalytic mechanism and a distinct substrate binding mechanism compared with neutral endopeptidase-24.11. Biochem. J. 1996, 315:863-867.
28. Hoang M.V., Sansom C.E., Turner A.J. Mutagenesis of Glu (403) to Cys in rabbit neutral endopeptidase-24.11 (neprilysin) creates a disulphide-linked homodimer: analogy with endothelin-converting enzyme. Biochem. J. 1996, 327:925-929.
29. Oefner C., D'Arcy A., Hennig M., Winkler F.K., Dale G.E. Structure of human neutral endopeptidase (neprilysin) complexed with phosphoramidon. J. Mol. Biol. 2000, 296:341-349.
30. Schulz H., Dale G.E., Karimi-Nejad Y., Oefner C. Structure of human endothelin-converting enzyme I complexed with phosphoramidon. J. Mol. Biol. 2009, 385:178-187.
31. Tam L.T., Engelbrecht S., Talent J.M., Gracy R.W., Erdös E.G. The importance of disulfide bridges in human endopeptidase (enkephalinase) after proteolytic cleavage. Biochem. Biophys. Res. Commun. 1985, 133:1187-1192.
32. Relton J.M., Gee N.S., Matsas R., Turner A.J., Kenny A.J. Purification of endopeptidase-24.11 ('enkephalinase') from pig brain by immunoadsorbent chromatography. Biochem. J. 1983, 215:519-523.
33. Malfroy B., Schofield P.R., Kuang W.J., Seeburg P.H., Mason A.J., Henzel W.J. Molecular cloning and amino acid sequence of rat enkephalinase. Biochem. Biophys. Res. Commun. 1987, 144:59-66.
34. Malfroy B., Kuang W.J., Seeburg P.H., Mason A.J., Schofield P.R. Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase). FEBS Lett. 1988, 229:206-210.
35. Tiraboschi G., Jullian N., Thery V., Antonczak S., Fournié-Zaluski M.C., Roques B.P. A three-dimensional construction of the active site (region 507-749) of human neutral endopeptidase (EC.3.4.24.11). Protein Eng. 1999, 12:141-149.
36. Mierau I., Tan P.S.T., Haandrikman A.J., Kok J., Leenhouts K.J., Konings W.N., Venema G. Cloning and sequencing of the gene for a lactococcal endopeptidase, an enzyme with sequence similarity to mammalian enkephalinase. J. Bacteriol. 1993, 175:2087-2096.
37. Awano S., Ansai T., Mochizuki H., Yu W.X., Tanzawa K., Turner A.J., Takehara T. Sequencing, expression and biochemical characterization of the Porphyromonas gingivalis pepO gene encoding a protein homologous to human endothelin-converting enzyme. FEBS Lett. 1999, 460:139-144.
38. Almenoff J., Orlowski M. Membrane-bound kidney neutral metalloendopeptidase: interaction with synthetic substrates, natural peptides, and inhibitors. Biochemistry 1983, 22:590-599.
39. Fossiez F., Lemay G., Labonte N., Parmentier-Lesage F., Boileau G., Crine P. Secretion of a functional soluble form of neutral endopeptidase-24.11 from a baculovirus-infected insect cell line. Biochem. J. 1992, 284:53-59.
40. Howell S., Murray H., Turner A.J., Kenny A.J. A highly sensitive elisa for endopeptidase-24.11, the common acute lymphoblastic leukemia antigen (CALLA, CD-10), applicable to material of porcine and human origin. Biochem. J. 1991, 278:417-421.
41. Barnes K., Turner A.J., Kenny A.J. An immunoelectron microscopic study of pig substantia nigra shows co-localisation of endopeptidase-24.11 with substance P. Neuroscience 1993, 53:1073-1082.
42. Carson J.A., Turner A.J. β-Amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?. J. Neurochem. 2002, 81:1-8.
43. Hersh L.B., Rodgers D.W. Neprilysin and amyloid beta peptide degradation. Curr. Alzheimer Res. 2008, 5:225-231.
44. Barnes K., Matsas R., Hooper N.M., Turner A.J., Kenny A.J. Endopeptidase-24.11 is striosomally ordered in pig brain and, in contrast to aminopeptidase N and peptidyl dipeptidase A ('angiotensin converting enzyme') is a marker for a set of striatal efferent fibres. Neuroscience 1988, 27:799-817.
45. Barnes K., Doherty S., Turner A.J. Endopeptidase-24.11 is the integral membrane peptidase initiating degradation of somatostatin in the hippocampus. J. Neurochem. 1995, 64:1826-1832.
46. Akiyama H., Kondo H., Ikeda K., Kato M., McGeer P.L. Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid β-protein (Aβ) deposition. Brain Res. 2001, 902:277-281.
47. Fukami S., Watanabe K., Iwata N., Haraoka J., Lu B., Gerard N.P., Gerard C., Fraser P., Westaway D., George-Hyslop P., Saido T.C. Aβ-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Aβ pathology. Neurosci. Res. 2002, 43:39-56.
48. Howell S., Nalbantoglu J., Crine P. Neutral endopeptidase can hydrolyze β-amyloid (1-40) but shows no effect on β-amyloid precursor protein metabolism. Peptides 1995, 16:647-652.
49. Iwata N., Tsubuki S., Takaki Y., Watanabe K., Seikiguchi M., Hosoki E., Kawashima-Morishima M., Lee H.-J., Hama E., Sekine-Aizawa Y., Saido T.C. Identification of the major Aβ1-42 degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition. Nature Med. 2000, 6:143-150.
50. Iwata N., Tsubuki S., Takaki Y., Shirotani K., Lu B., Gerard N.P., Gerard C., Hama E., Lee H., Saido T.C. Metabolic regulation of brain Aβ by neprilysin. Science 2001, 292:1550-1552.
51. Nalivaeva N.N., Fisk L., Kochkina E.G., Plesneva S.A., Zhuravin I.A., Babusikova E., Dobrota D., Turner A.J. Effect of hypoxia/ischemia and hypoxic preconditioning/reperfusion on expression of some amyloid-degrading enzymes. Ann. NY Acad. Sci. 2004, 1035:21-33.
52. Marr R.A., Rockenstein E., Mukherjee A., Kindy M.S., Hersh L.B., Gage F.H., Verma I.M., Masliah E. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J. Neurosci. 2003, 23:1992-1996.
53. Pardossi-Piquard R., Petit A., Kawarai T., Sunyach C., Alves da Costa C., Vincent B., Ring S., D'Adamio L., Shen J., Müller U., George Hyslop P., Checler F. Presenilin-dependent transcriptional control of the Aβ-degrading enzyme neprilysin by intracellular domains of βAPP and APLP. Neuron 2005, 46:541-554.
54. Belyaev N.D., Nalivaeva N.N., Makova N.Z., Turner A.J. Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease. EMBO Rep. 2009, 10:94-100.
55. Belyaev N.D., Kellett K.A., Beckett C., Makova N.Z., Revett T.J., Nalivaeva N.N., Hooper N.M., Turner A.J. The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a β-secretase-dependent pathway. J. Biol. Chem. 2010, 285:41443-41454.
56. Nalivaeva N.N., Belyaev N.D., Turner A.J. Sodium valproate: an old drug with new roles. Trends Pharmacol. Sci. 2009, 30:509-514.
57. Le Bien T.W., McCormack R.T. The common acute lymphoblastic leukaemia antigen (CD10) - emancipation from a functional enigma. Blood 1989, 73:625-634.
58. Papandreou C.N., Usmani B., Geng Y.P., Bogenrieder T., Freeman R., Wilk S., Finstad C.L., Reuter V.E., Powell C.T., Scheinberg D., Magill C., Scher H.I., Albino A.P., Nanus D.M. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nature Med. 1998, 4:50-57.
59. Gohring B., Holzhausen H.J., Meye A., Heynemann H., Rebmann U., Langner J., Riemann D. Endopeptidase24.11/CD10 is down-regulated in renal cell cancer. Int. J. Mol. Med. 1998, 2:409-414.
60. Cohen A.J., Bunn P.A., Franklin W., Magill-Solc C., Hartmann C., Helfrich B., Gilman L., Folkvord J., Helm K., Miller Y.E. Neutral endopeptidase: Variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. Cancer Res. 1996, 56:831-839.
61. Usmani B.A., Shen R., Janeczko M., Papandreou C.N., Lee W.H., Nelson W.G., Nelson J.B., Nanus D.M. Methylation of the neutral endopeptidase gene promoter in human prostate cancers. Clin. Cancer Res. 2000, 6:1664-1670.
62. Dai J., Shen R.Q., Sumitomo M., Goldberg J.S., Geng Y.P., Navarro D., Xu S., Koutcher J.A., Garzotto M., Powell C.T., Nanus D.M. Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells. Clin. Cancer Res. 2001, 7:1370-1377.
63. Shen R.Q., Sumitomo M., Dai J., Hardy D.O., Navarro D., Usmani B., Papandreou C.N., Hersh L.B., Shipp M.A., Freedman L.P., Nanus D.M. Identification and characterization of two androgen response regions in the human neutral endopeptidase gene. Mol. Cell Endocrinol. 2000, 170:131-142.
64. Xiao Z.M., Sun L., Liu Y.M., Zhang J.J., Huang J. Estrogen regulation of the neprilysin gene through a hormone-responsive element. J. Mol. Neurosci. 2009, 39:22-26.
65. Hong Y., Beckett C., Belyaev N.D., Turner A.J. The impact of amyloid precursor protein signalling and histone deacetylase inhibition on neprilysin expression in human prostate cells. Int. J. Cancer 2011, 130:775-786.
66. Bralet J., Schwartz J.C. Vasopeptidase inhibitors: an emerging class of cardiovascular drugs. Trends Pharmacol. Sci. 2001, 22:106-109.
67. Corti R., Burnett J.C., Rouleau J.L., Ruschitzka F., Luscher T.F. Vasopeptidase inhibitors - A new therapeutic concept in cardiovascular disease?. Circulation 2001, 104:1856-1862.
68. Campbell D.J. Vasopeptidase inhibition: a double-edged sword?. Hypertension 2003, 41:383-389.
69. Pryde, D.C., Cook, A.S., Burring, D.J., Jones, L.H., Foll, S., Platts, M.Y., Sanderson, V., Corless, M., Stobie, A., Middleton, D.S., Foster, L., Barker, L., Van Der Graaf, P., Stacey, P., Kohl, C., Coggon, S., Beaumont, K. (2007). Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder. Bioorg. Med. Chem. 15, 142-159.
70. Howell S., Murray H., Turner A.J., Kenny A.J. A highly sensitive elisa for endopeptidase-24.11, the common acute lymphoblastic leukemia antigen (CALLA, CD-10), applicable to material of porcine and human origin. Biochem. J. 1991, 278:417-421.
71. Ruchon A.F., Marcinkiewicz M., Ellefsen K., Basak A., Aubin J., Crine P., Boileau G. Cellular localization of neprilysin in mouse bone tissue and putative role in hydrolysis of osteogenic peptides. J. Bone Min. Res. 2000, 15:1266-1274.
72. Borson D.B. Roles of neutral endopeptidase in airways. Am. J. Physiol. 1991, 260:L212-L225.
73. Becker M., Siems W.E., Kluge R., Gembardt F., Schultheiss H.P., Schirner M., Walther T. New function for an old enzyme: NEP deficient mice develop late-onset obesity. PLoS One 2010, 5:e12793.
74. Standeven K.F., Hess K., Carter A.M., Rice G.I., Cordell P.A., Balmforth A.J., Lu B., Scott D.J., Turner A.J., Hooper N.M., Grant P.J. Neprilysin, obesity and the metabolic syndrome. Int. J. Obes. 2010, 35:1031-1040.
75. Ganju R.K., Shpektor R.G., Brenner D.G., Shipp M.A. CD10/neutral endopeptidase 24.11 is phosphorylated by casein kinase II and coassociates with other phosphoproteins including the lyn src-related kinase. Blood 1996, 88:4159-4165.
76. Sumitomo M., Shen R.Q., Walburg M., Dai J., Geng Y.P., Navarro D., Boileau G., Papandreou C.N., Giancotti F.G., Knudsen B., Nanus D.M. Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling. J. Clin. Invest. 2000, 106:1399-1407.
77. Santos A.N., Wulfanger J., Helbing G., Blosz T., Langner J., Riemann D. Two C-terminal cysteines are necessary for proper folding of the peptidase neprilysin/CD10. Biochem. Biophys. Res. Commun. 2002, 295:423-427.
78. Zheng R., Horiguchi A., Iida K., Lee J., Shen R., Goodman O.B., Nanus D.M. Neutral endopeptidase is a myristoylated protein. Mol. Cell Biochem. 2010, 335:173-180.
79. Iwase A., Shen R., Navarro D., Nanus D.M. Direct binding of neutral endopeptidase 24.11 to ezrin/radixin/moesin (ERM) proteins competes with the interaction of CD44 with ERM proteins. J. Biol. Chem. 2004, 279:11898-11905.
80. Siepmann M., Kumar S., Mayer G., Walter J. Casein kinase 2 dependent phosphorylation of neprilysin regulates receptor tyrosine kinase signaling to Akt. PLoS One 2010, 5:e13134.
81. D'Adamio L., Shipp M.A., Masteller E.L., Reinherz E.L. Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5' untranslated regions. Proc. Natl. Acad. Sci. USA 1989, 86:7103-7107.
82. Li C., Booze R.M., Hersh L.B. Tissue-specific expression of rat neutral endopeptidase (neprilysin) mRNAs. J. Biol. Chem. 1995, 270:5723-5728.
83. Lu B., Gerard N.P., Kolakowski L.F., Bozza M., Zurakowski D., Finco O., Carroll M.C., Gerard C. Neutral endopeptidase modulation of septic shock. J. Exp. Med. 1995, 181:2271-2275.
84. Bonvouloir N., Lemieux N., Crine P., Boileau G., DesGroseillers L. Molecular cloning, tissue distribution, and chromosomal localization of MMEL2, a gene coding for a novel human member of the neutral endopeptidase-24.11 family. DNA Cell Biol. 2001, 20:493-498.
85. Ikeda K., Emoto N., Raharjo S.B., Nurhantari Y., Saiki K., Yokoyama M., Matsuo M. Molecular identification and characterisation of a novel membrane-bound metalloprotease, the souble form of which hydrolyzes a variety of vasoactive peptides. J. Biol. Chem. 1999, 274:32469-32477.
86. Ghaddar G., Ruchon A.F., Carpentier M., Marcinkiewicz M., Seidah N.G., Crine P., DesGroseillers L., Boileau G. Molecular cloning and biochemical characterization of a new mouse testis soluble-zinc-metallopeptidase of the neprilysin family. Biochem. J. 2000, 347:419-429.
87. Ouimet T., Facchinetti P., Rose C., Bonhomme M.-C., Gros C., Schwartz J.-C. Neprilysin II, a putative novel metalloprotease and its isoforms in CNS and testis. Biochem. Biophys. Res. Commun. 2000, 271:565-570.
88. Whyteside A.R., Turner A.J. Human neprilysin-2 (NEP2) and NEP display distinct subcellular localisations and substrate preferences. FEBS Lett. 2008, 582:2382-2386.
89. Valdenaire O., Rohrbacher E., Langeveld A., Schweizer A., Meijers C. Organisation and chromosomal localization of the human ECEL1 (XCE) gene encoding a zinc metallopeptidase involved in the nervous control of respiration. Biochem. J. 2000, 346:611-616.
90. Kiryu-Seo S., Sasaki M., Yokohama H., Nakagomi S., Hirayama T., Aoki S., Wada K., Kiyama H. Damage-induced neuronal endopeptidase (DINE) is a unique metallopeptidase expressed in response to neuronal damage and activates superoxide scavengers. Proc. Natl. Acad. Sci. USA 2000, 97:4345-4350.
91. Rose C., Voisin S., Gros C., Schwartz J.C., Ouimet T. Cell-specific activity of neprilysin 2 isoforms and enzymic specificity compared with neprilysin. Biochem. J. 2002, 363:697-705.
92. Turner, A.J., Nalivaeva, N.N. Proteinase dysbalance in pathology: the neprilysin (NEP) and angiotensin-converting enzyme (ACE) families. Cell Mol. Biol. 52, 40-48.